2014Zhonghua laonian xin-nao-xueguanbing zazhiRequires access

Effect of trimetazidine and ramipril on myocardial cell apoptosis and Caspase-3 expression in heart failure rats

Feng Xiang-y

Open publisher page 0 citations

Abstract

Objective To study the effect of trimetazidine or ramipril alone and their combination on myocardial cell apoptosis and Caspase-3expression in chronic heart failure rats.Methods Fifty male Wistar rats were randomly divided into sham operation group,model group,trimetazidine group,ramipril group and combined treatment(trimetazidine and ramipril)group(10in each group).A chronic heart failure model was established by suprarenal aortic constriction.LVEDP and±dp/dtmaxwere recorded,AI of myocardial cells was assayed by TUNEL,expressions of Caspase-3protein and mRNA were detected by SP immunohistochemistry and RT-PCR respectively in different groups.Results The LVEDP,AI and the expression levels of Caspase-3protein and mRNA were significantly lower in trimetazidine group,ramipril group and combined treatment group than in model group(0.14±0.01 vs 0.22±0.02,0.14±0.02 vs 0.54±0.02,0.08±0.02 vs 0.54±0.02,and 0.32±0.02,0.91±0.02,P0.01)while the±dp/dtmaxwas significantly higher in trimetazidine group,ramipril group and combined treatment group than in model group.Conclusion Trimetazidine or ramipril alone and their combination can effectively improve cardiac function and inhibit myocardial cell apoptosis in chronic heart failure rats.The therapeutic effect of combined trimetazidine and ramipril is better than that of trimetazidine or ramipril alone.

About this research paper

What this paper is about

Objective To study the effect of trimetazidine or ramipril alone and their combination on myocardial cell apoptosis and Caspase-3expression in chronic heart failure rats.Methods Fifty male Wistar rats were randomly divided into sham operation group,model group,trimetazidine group,ramipril group and combined treatment(trimetazidine and ramipril)group(10in each group).A chronic heart failure model was established by suprarenal aortic constriction.LVEDP and±dp/dtmaxwere recorded,AI of myocardial cells was assayed by TUNEL,expressions of Caspase-3protein and mRNA were detected by SP immunohistochemistry and RT-PCR respectively in different groups.Results The LVEDP,AI and the expression levels of Caspase-3protein and mRNA were significantly lower in trimetazidine group,ramipril group and combined treatment group than in model group(0.14±0.01 vs 0.22±0.02,0.14±0.02 vs 0.54±0.02,0.08±0.02 vs 0.54±0.02,and 0.32±0.02,0.91±0.02,P0.01)while the±dp/dtmaxwas significantly higher in trimetazidine group,ramipril group and combined treatment group than in model group.Conclusion Trimetazidine or ramipril alone and their combination can effectively improve cardiac function and inhibit myocardial cell apoptosis in chronic heart failure rats.The therapeutic effect of combined trimetazidine and ramipril is better than that of trimetazidine or ramipril alone.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To study the effect of trimetazidine or ramipril alone and their combination on myocardial cell apoptosis and Caspase-3expression in chronic heart failure rats.Methods Fifty male Wistar rats were randomly divided into sham operation group,model group,trimetazidine group,ramipril group and combined treatment(trimetazidine and ramipril)group(10in each group).A chronic heart failure model was established by suprarenal aortic constriction.LVEDP and±dp/dtmaxwere recorded,AI of myocardial cells was assayed by TUNEL,expressions of Caspase-3protein and mRNA were detected by SP immunohistochemistry and RT-PCR respectively in different groups.Results The LVEDP,AI and the expression levels of Caspase-3protein and mRNA were significantly lower in trimetazidine group,ramipril group and combined treatment group than in model group(0.14±0.01 vs 0.22±0.02,0.14±0.02 vs 0.54±0.02,0.08±0.02 vs 0.54±0.02,and 0.32±0.02,0.91±0.02,P0.01)while the±dp/dtmaxwas significantly higher in trimetazidine group,ramipril group and combined treatment group than in model group.Conclusion Trimetazidine or ramipril alone and their combination can effectively improve cardiac function and inhibit myocardial cell apoptosis in chronic heart failure rats.The therapeutic effect of combined trimetazidine and ramipril is better than that of trimetazidine or ramipril alone.

Key concepts: Trimetazidine, Ramipril, Medicine, Preload, Apoptosis, TUNEL assay, Internal medicine, ACE inhibitor

Related papers

Back to paper searchBrowse research topicsOriginal source
Effect of trimetazidine and ramipril on myocardial cell apoptosis and Caspase-3 expression in heart failure rats — Research Paper | ScholarLens